Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
HART > SEC Filings for HART > Form 8-K on 31-Oct-2013All Recent SEC Filings




Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.

On October 31, 2013, Harvard Bioscience, Inc. ("HBIO"), the parent of Harvard Apparatus Regenerative Technology, Inc. ("HART"), issued a press release announcing its financial results for the three and nine months ended September 30, 2013. The press release is furnished as Exhibit 99.1 and incorporated herein by reference.

HBIO has also scheduled a conference call to discuss HBIO's third quarter financial results for October 31, 2013 at 11:00 AM ET. Participating in the call will be Jeffrey A. Duchemin, Chief Executive Officer; David Green, President; Tom McNaughton, Chief Financial Officer; and Robert Gagnon, Executive Vice President-Finance, each of HBIO. In addition to discussing the third quarter financial results, management of HBIO expects to discuss the spin-off of HART, and HBIO's business strategies. Management of HBIO may also answer questions concerning business and financial developments and trends, and other matters affecting the company. Some of the information to be presented on the call or provided in response to questions may contain information that has not previously been disclosed by HBIO or HART.

The conference call will be simultaneously broadcast over the Internet and can be accessed through the Harvard Bioscience, Inc. website. To listen to the conference call, log on to the website at and click on the Earnings Call icon. Financial and other statistical information presented on the call, including the earnings release, will also be available on the investor relations section of the HBIO website. Click on the investor relations button and then click on the press release or webcast icon, as appropriate. If you are unable to listen to the live webcast, the call will be archived in the investor relations section of the HBIO website. The live conference call is also accessible by dialing toll-free 877-303-7611, or toll 970-315-0445, and referencing the pass code of "89708444". A replay of this conference call will be available from approximately 2:00 PM ET on October 31, 2013 through November 9, 2013 and will be accessible by dialing toll-free 855-859-2056, or toll 404-537-3406, and referencing the pass code of "89708444".

The information in this Item 2.02 and Item 8.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Number    Title

          Press release of Harvard Bioscience, Inc. issued on October 31, 2013.
99.1      Incorporated by reference to Exhibit 99.1 of the Form 8-K filed with the
          SEC on October 31, 2013.

  Add HART to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for HART - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.